[Chart: Jafron logo]
Jafron Biomedical Co., Ltd.
2026 Semi-Annual Report
August 2026
Stock Code: 300529 Stock Abbreviation: Jafron Biomedical Announcement No.: 2026-045
Bond Code: 123117 Bond Abbreviation: Jafron Convertible Bonds
Section I: Important Notices, Table of Contents, and Definitions
The Board of Directors, the Board of Supervisors, and the directors, supervisors, and senior management of the Company guarantee that the information in this semi-annual report is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions. They assume individual and joint legal liability for the content.
Company Chairman Dong Fan, Chief Financial Officer Liao Xueyun, and Head of Accounting Department (Accounting Supervisor) Li Ziyun declare: We guarantee the truth, accuracy, and completeness of the financial statements in this semi-annual report.
All directors attended the board meeting to review this semi-annual report.
This report contains forward-looking statements regarding business plans, future plans, and development strategies, which do not constitute substantive commitments or profit forecasts by the Company to investors. Realization depends on market conditions and other factors; investors are advised to be aware of investment risks.
The Company has detailed the potential risk factors and countermeasures for its future development in this report. Please refer to "Section III: Management Discussion and Analysis" under "X. Risks Faced by the Company and Countermeasures." Investors are advised to be aware of investment risks.
The Company plans not to distribute cash dividends, not to issue bonus shares, and not to convert capital reserves into share capital.
Table of Contents
| Section | Page |
|---|---|
| Section I: Important Notices, Table of Contents, and Definitions | 2 |
| Section II: Company Profile and Key Financial Indicators | 6 |
| Section III: Management Discussion and Analysis | 9 |
| Section IV: Corporate Governance, Environment, and Society | 26 |
| Section V: Important Matters | 28 |
| Section VI: Changes in Shares and Shareholders | 32 |
| Section VII: Bond-Related Information | 38 |
| Section VIII: Financial Report | 42 |
List of Documents Available for Inspection
-
Financial statements signed and sealed by the Company's legal representative, the person in charge of accounting, and the head of the accounting department.
-
Originals of all company documents and announcements publicly disclosed on the website designated by the CSRC during the reporting period.
Location of the above documents: Office of the Board Secretary.